Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 165, Issue 1, 2012, Pages 96-103

  Huang, Yiping ^a   Zhang, Xiaoyan ^a   Jiang, Wei ^a   Wang, Yisheng ^a   Jin, Hong ^a   Liu, Xiaohui ^a   Xu, Congjian ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Animal model; Biomarker; Carcinogenesis; Proteomics; Serous ovarian cancer

Indexed keywords

ALPHA TUBULIN; ANTITHROMBIN III; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; CERULOPLASMIN; COMPLEMENT FACTOR H; DIMETHYLBENZ[A]ANTHRACENE; GELSOLIN; HEMOPEXIN; HISTIDINE; PEPTIDE; PLASMINOGEN; SERINE PROTEINASE INHIBITOR; THROMBOSPONDIN 1; VITAMIN D BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DATA ANALYSIS; DATA ANALYSIS SOFTWARE; DISEASE COURSE; DOWN REGULATION; EARLY DIAGNOSIS; EXTRACELLULAR MATRIX; FEMALE; ITRAQ TECHNIQUE; LIQUID CHROMATOGRAPHY; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SURVIVAL RATE; TANDEM MASS SPECTROMETRY; UPREGULATION;

EID: 84869087672     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2012.06.031     Document Type: Article

References (30)

1. A.M. Lutz, J.K. Willmann, and C.W. Drescher Early diagnosis of ovarian carcinoma: is a solution in sight? Radiology 259 2011 329 345
2. S. Sekiya, N. Endoh, and Y. Kikuchi In vivo and in vitro studies of experimental ovarian adenocarcinoma in rats Cancer Research 39 1979 1108 1112 (Pubitemid 9135142)
3. T. Nishida, T. Sugiyama, A. Kataoka, K. Ushijima, and M. Yakushiji Histologic characterization of rat ovarian carcinoma induced by intraovarian insertion of a 7,12-dimethylbenz[a]anthracene-coated suture: common epithelial tumors of the ovary in rats? Cancer 83 1998 965 970 (Pubitemid 28401931)
4. K.A. Crist, Z. Zhang, and M. You Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture Carcinogenesis 26 2005 951 957 (Pubitemid 41214324)
5. J.C. Tunca, E. Erturk, E. Erturk, and G.T. Bryan Chemical induction of ovarian tumors in rats Gynecologic Oncology 21 1985 54 64 (Pubitemid 15116026)
6. K.K. Kim, J.C. Shim, and J.R. Kim Overexpression of p21, cyclin E and decreased expression of p27 in DMBA (7,12-dimethylbenzanthracene)-induced rat ovarian carcinogenesis Pathology International 53 2003 291 296 (Pubitemid 36737024)
7. M.S. O'Reilly, S. Pirie-Shepherd, W.S. Lane, and J. Folkman Antiangiogenic activity of the cleaved conformation of the serpin antithrombin Science 285 1999 1926 1928
8. A.G. Wang, S.Y. Yoon, and J.H. Oh Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags Biochemical and Biophysical Research Communications 345 2006 1022 1032 (Pubitemid 43776521)
9. S.Y. Yoon, J.M. Kim, and J.H. Oh Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags International Journal of Oncology 29 2006 315 327
10. K. Valk, T. Vooder, and R. Kolde Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers Oncology-Basel 79 2010 283 292
11. S. Sakamoto, R.O. McCann, R. Dhir, and N. Kyprianou Talin-1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance Cancer Research 70 2010 1885 1895
12. M.T. Lai, C.H. Hua, and M.H. Tsai Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis Journal of Pathology 224 2011 367 376
13. H.C. Kwaan, and B. McMahon The role of plasminogen-plasmin system in cancer Cancer Treatment and Research 148 2009 43 66
14. P. Murthi, G. Barker, and C.J. Nowell Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression Gynecologic Oncology 92 2004 80 88 (Pubitemid 38147375)
15. P. Dowling, C. Clarke, and K. Hennessy Analysis of acute phase proteins, AHSG, C3, CLI, HP and SAA reveals distinctive expression patterns associated with breast, colorectal and lung cancer International Journal of Cancer 131 2012 911 923
16. B. Guillory, A.M. Sakwe, and M. Saria Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer American Journal of Pathology 177 2010 2635 2644
17. M.N. Kundranda, M. Henderson, and K.J. Carter The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms Cancer Research 65 2005 499 506
18. C.J. Swallow, E.A. Partridge, and J.C. Macmillan Alpha2hs-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression Cancer Research 64 2004 6402 6409 (Pubitemid 39297893)
19. F. Su, K.R. Kozak, and S. Imaizumi Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer Proceedings of the National Academy of Sciences of the United States of America 107 2010 19997 20002
20. Y. Fan, L. Shi, and Q. Liu Discovery and identification of potential biomarkers of papillary thyroid carcinoma Molecular Cancer 8 2009 79
21. Y. Fan, J. Wang, and Y. Yang Detection and identification of potential biomarkers of breast cancer Journal of Cancer Research and Clinical Oncology 136 2010 1243 1254
22. J.Y. Engwegen, A.C. Depla, and M.E. Smits Detection of colorectal cancer by serum and tissue protein profiling: a prospective study in a population at risk Biomark Insights 3 2008 375 385
23. Y. Yang, S. Zhao, and Y. Fan Detection and identification of potential biomarkers of non-small cell lung cancer Technology in Cancer Research and Treatment 8 2009 455 466
24. M. Cohen, R. Yossef, and T. Erez Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays PLoS ONE 6 1 2011 e14540
25. J. Chen, M. Anderson, D.E. Misek, D.M. Simeone, and D.M. Lubman Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometry Journal of Chromatography A 1162 2007 117 125 (Pubitemid 47187399)
26. K. Bijian, A.M. Mlynarek, and R.L. Balys Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment Journal of Proteome Research 8 2009 2173 2185
27. C.S. Ang, J. Rothacker, H. Patsiouras, A.W. Burgess, and E.C. Nice Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer Journal of Chromatography A 1217 2010 3330 3340
28. P. Dowling, L. O'Driscoll, and P. Meleady 2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins Electrophoresis 28 2007 4302 4310 (Pubitemid 350259032)
29. M. Onda, J. Akaishi, and S. Asaka Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth British Journal of Cancer 92 2005 2216 2224 (Pubitemid 40966260)
30. B. Jarzab, M. Wiench, and K. Fujarewicz Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications Cancer Research 65 2005 1587 1597 (Pubitemid 40270189)